Literature DB >> 9690432

"Buffalo hump" in HIV-1 infection.

T Saint-Marc, J L Touraine.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9690432     DOI: 10.1016/S0140-6736(05)60293-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Indinavir: a review of its use in the management of HIV infection.

Authors:  G L Plosker; S Noble
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

Review 2.  Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed?

Authors:  G M Behrens; M Stoll; R E Schmidt
Journal:  Drug Saf       Date:  2000-07       Impact factor: 5.606

3.  Solute mass balance during isovolaemic high volume haemofiltration.

Authors:  Shigehiko Uchino; Louise Cole; Hiroshi Morimatsu; Donna Goldsmith; Claudio Ronco; Rinaldo Bellomo
Journal:  Intensive Care Med       Date:  2003-07-10       Impact factor: 17.440

Review 4.  Metabolic complications associated with HIV protease inhibitor therapy.

Authors:  David Nolan
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 5.  Saquinavir soft gelatin capsule: a comparative safety review.

Authors:  J Gill; J Feinberg
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228

6.  Development of Buffalo Hump in the course of antiretroviral therapy including raltegravir and unboosted atazanavir: a case report and review of the literature.

Authors:  Giancarlo Ceccarelli; Gabriella d'Ettorre; Francesco Marchetti; Cecilia Rizza; Claudio M Mastroianni; Bruno Carlesimo; Vincenzo Vullo
Journal:  J Med Case Rep       Date:  2011-02-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.